8-K Announcements
6Material company update
Apr 22, 2026·SEC
Material company update
Apr 17, 2026·SEC
Material company update
Mar 18, 2026·SEC
SRx Health Solutions Inc.(SRXH)Earnings, Financials & Key Ratios
SRXH•NYSE
Price updated Jun 19, 2026
AboutSRx Health Solutions Inc. is an integrated Canadian healthcare services provider operating within the specialty healthcare industry. The company offers comprehensive, integrated, and customized specialty healthcare services across all ten Canadian provinces. SRx combines industry knowledge, technology, and a patient-centric focus to create strategies and solutions aimed at improving the wellness of Canadians.Show more
- Revenue$7M-81.3%
- EBITDA-$11M-97.0%
- Net Income-$45M-26689.3%
- EPS (Diluted)-2.13-2030.0%
- Gross Margin22.88%-37.8%
- EBITDA Margin-175.99%-954.5%
- Operating Margin-176.46%-934.3%
- Net Margin-688.8%-143309.8%
- ROE-994.06%-6876.9%
SRXH Key Insights
SRx Health Solutions Inc. (SRXH) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
No significant strengths identified
✗Weaknesses
- ✗High debt to equity ratio of 11.0x
- ✗Weak Piotroski F-Score: 3/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 13 (bottom 13%)
- ✗Low quality earnings: Net income not backed by cash flow
- ✗Sales declining 31.3% over 5 years
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
Get notified when SRXH posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
SRXH Price & Volume
SRx Health Solutions Inc. (SRXH) stock price & volume — 10-year historical chart
Loading chart...
SRXH Growth Metrics
SRx Health Solutions Inc. (SRXH) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-31.27%
3 Years-58.68%
TTM-127.54%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-594.45%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-252.26%
Return on Capital
10 Years-95.96%
5 Years-95.96%
3 Years-141.73%
Last Year-170.66%
SRXH Peer Comparison
SRx Health Solutions Inc. (SRXH) competitors in Generics and biosimilars manufacturers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 OPRX | 93.45M | 4.98 | 18.44 | 18.78% | 6.37% | 5.47% | 0.20 | |
 HIMS | 7.79B | 35.47 | 69.55 | 59% | -0.56% | -2.48% | 2.34 | |
 PHVS | 2.15B | 32.80 | -9.60 | -67.38% | 0.00 | |||
 TDOC | 1.46B | 8.07 | -7.08 | -1.54% | -6.81% | -12.37% | 0.75 | |
 ALHC | 4.47B | 21.86 | -5908.11 | 46.06% | 0.47% | 11.5% | 1.89 | |
 CVS | 125.45B | 98.32 | 70.73 | 7.85% | 0.72% | 3.86% | 1.24 | |
 MCK | 90.23B | 750.63 | 19.56 | 12.36% | 1.18% | |||
 CAH | 52.19B | 221.77 | 34.38 | -1.87% | 0.62% |
Compare SRXH vs Peers
SRx Health Solutions Inc. (SRXH) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
SRXH Income Statement
SRx Health Solutions Inc. (SRXH) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Metric | Dec'20 | Dec'21 | Sep'22 | Sep'23 | Dec'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|
Sales/Revenue | 42.59M | 46.01M | 92.63M | 118.94M | 34.98M | 6.53M | -16.86M |
Revenue Growth % | - | 8.02% | 101.35% | 28.4% | -70.59% | -81.32% | -127.54% |
Cost of Goods Sold | 28.24M | 32.3M | 79.33M | 95.33M | 22.12M | 5.04M | -12.09M |
COGS % of Revenue | 66.3% | 70.21% | 85.64% | 80.15% | 63.23% | 77.12% | - |
Gross Profit | 14.35M▲ 0% | 13.7M▼ 4.5% | 13.31M▼ 2.9% | 23.61M▲ 77.5% | 12.86M▼ 45.5% | 1.5M▼ 88.4% | -4.76M▲ 0% |
Gross Margin % | 33.7% | 29.79% | 14.36% | 19.85% | 36.77% | 22.88% | 28.25% |
Gross Profit Growth % | - | -4.51% | -2.91% | 77.45% | -45.54% | -88.37% | - |
Operating Expenses | 41.67M | 30.98M | 14.47M | 29.42M | 18.83M | 13.03M | -5.35M |
OpEx % of Revenue | 97.85% | 67.35% | 15.62% | 24.73% | 53.83% | 199.34% | - |
Selling, General & Admin | 41.67M | 30.98M | 13.14M | 29.49M | 18.73M | 13.03M | 17.44M |
SG&A % of Revenue | 97.85% | 67.35% | 14.19% | 24.8% | 53.54% | 199.34% | - |
Research & Development | 0 | 0 | 0 | 0 | 100K | 0 | 0 |
R&D % of Revenue | - | - | - | - | 0.29% | - | - |
Other Operating Expenses | 0 | 0 | 1.33M | -75.1K | 0 | 0 | -1000K |
Operating Income | -27.32M▲ 0% | -17.28M▲ 36.8% | -1.17M▲ 93.2% | -5.81M▼ 397.9% | -5.97M▼ 2.7% | -11.53M▼ 93.2% | 589K▲ 0% |
Operating Margin % | -64.15% | -37.56% | -1.26% | -4.88% | -17.06% | -176.46% | -3.49% |
Operating Income Growth % | - | 36.76% | 93.25% | -397.9% | -2.75% | -93.23% | - |
EBITDA | -25.57M | -15.62M | -539.4K | -4.1M | -5.84M | -11.5M | 4.79M |
EBITDA Margin % | -60.05% | -33.94% | -0.58% | -3.45% | -16.69% | -175.99% | -28.42% |
EBITDA Growth % | - | 38.94% | 96.55% | -660.81% | -42.23% | -97% | 429.78% |
D&A (Non-Cash Add-back) | 1.75M | 1.66M | 627.01K | 1.7M | 130K | 31K | 4.2M |
EBIT | -50.09M | 6.64M | -1.17M | -8.76M | 308K | -11.53M | -41.68M |
Net Interest Income | -9.25M | -3.22M | -753.71K | -2.05M | -467K | -628K | -5.38M |
Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense | 9.25M | 3.22M | 753.71K | 2.05M | 467K | 628K | 5.38M |
Other Income/Expense | -32.01M | 20.7M | -842.77K | -5.13M | 5.81M | 2.89M | -10.53M |
Pretax Income | -59.34M▲ 0% | 3.42M▲ 105.8% | -2.01M▼ 158.7% | -10.94M▼ 444.6% | -159K▲ 98.5% | -8.64M▼ 5333.3% | -9.94M▲ 0% |
Pretax Margin % | -139.32% | 7.44% | -2.17% | -9.2% | -0.45% | -132.22% | 58.98% |
Income Tax | 0 | 37K | 440.21K | 196.58K | 9K | 0 | -919K |
Effective Tax Rate % | 0% | 1.08% | -21.91% | -1.8% | -5.66% | 0% | 9.24% |
Net Income | -59.34M▲ 0% | 2.98M▲ 105.0% | -2.45M▼ 182.1% | -11.14M▼ 354.7% | -168K▲ 98.5% | -45.01M▼ 26689.3% | -45.39M▲ 0% |
Net Margin % | -139.32% | 6.49% | -2.64% | -9.36% | -0.48% | -688.8% | 269.29% |
Net Income Growth % | - | 105.03% | -182.06% | -354.72% | 98.49% | -26689.29% | -594.45% |
Net Income (Continuing) | -59.34M | 3.39M | -2.45M | -11.14M | -168K | -8.64M | -9.02M |
Discontinued Operations | 0 | 0 | 0 | 0 | 0 | -36.37M | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EPS (Diluted) | -319.69▲ 0% | 6.00▲ 101.9% | -3.48▼ 158.0% | -0.90▲ 74.1% | -0.10▲ 88.9% | -2.13▼ 2030.0% | -0.15▲ 0% |
EPS Growth % | - | 101.88% | -158% | 74.14% | 88.89% | -2030% | -252.26% |
EPS (Basic) | -319.69 | 6.59 | -3.48 | -0.90 | -0.10 | -2.13 | - |
Diluted Shares Outstanding | 185.93K | 497.79K | 704.18K | 12.39M | 1.62M | 21.11M | 299.07M |
Basic Shares Outstanding | 185.93K | 452.9K | 704.18K | 12.39M | 1.62M | 21.11M | 299.07M |
Dividend Payout Ratio | - | - | - | - | - | - | - |
SRXH Balance Sheet
SRx Health Solutions Inc. (SRXH) balance sheet — assets, liabilities & shareholders' equity
| Metric | Dec'20 | Dec'21 | Sep'22 | Sep'23 | Dec'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|
Total Current Assets | 17.56M | 43.92M | 14.8M | 25.13M | 15M | 8.13M | 43.15M |
Cash & Short-Term Investments | 3.99M | 28.94M | 1.66M | 2.07M | 3.07M | 1.31M | 26.07M |
Cash Only | 3.99M | 28.94M | 1.66M | 2.07M | 3.07M | 1.31M | 20.54M |
Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 5.53M |
Accounts Receivable | 4.63M | 6.79M | 3.38M | 7.06M | 7.74M | 3.94M | 5.21M |
Days Sales Outstanding | 39.69 | 53.89 | 13.32 | 21.66 | 80.79 | 220.37 | -110.23 |
Inventory | 4.87M | 5.25M | 4.02M | 5.72M | 3.37M | 2.08M | 2.09M |
Days Inventory Outstanding | 62.93 | 59.27 | 18.48 | 21.9 | 55.6 | 150.52 | -80.08 |
Other Current Assets | 2.29M | 845K | 5.31M | 9.56M | 825K | 794K | 9.78M |
Total Non-Current Assets | 33.69M | 33.5M | 19.99M | 39.38M | 800K | 276K | 215K |
Property, Plant & Equipment | 597K | 425K | 7.36M | 10.64M | 12.52M | 108K | 76K |
Fixed Asset Turnover | 71.34x | 108.25x | 12.59x | 11.18x | 2.79x | 60.50x | -8.38x |
Goodwill | 18.61M | 18.61M | 8.78M | 18.48M | 405K | 0 | 0 |
Intangible Assets | 13.12M | 11.59M | 3.78M | 9.79M | 7M | 0 | 0 |
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 1.36M | 116K | 61.54K | 473.41K | -18.87M | 168K | 139K |
Total Assets | 51.25M▲ 0% | 77.42M▲ 51.1% | 34.79M▼ 55.1% | 64.51M▲ 85.5% | 15.8M▼ 75.5% | 8.4M▼ 46.8% | 43.36M▲ 0% |
Asset Turnover | 0.83x | 0.59x | 2.66x | 1.84x | 2.21x | 0.78x | -0.60x |
Asset Growth % | - | 51.06% | -55.07% | 85.46% | -75.51% | -46.83% | 487.99% |
Total Current Liabilities | 54.58M | 7.34M | 22.04M | 65.5M | 7.15M | 3.54M | 25.08M |
Accounts Payable | 3.14M | 4.55M | 13.58M | 24.36M | 39.84M | 2.15M | 952K |
Days Payables Outstanding | 40.55 | 51.45 | 62.51 | 93.28 | 657.55 | 155.52 | -322.5 |
Short-Term Debt | 8.19M | 909K | 5.66M | 34.6M | 37.52M | 0 | 22.62M |
Deferred Revenue (Current) | 350K | 225K | 0 | 0 | 29K | 0 | 0 |
Other Current Liabilities | 41.99M | 899K | 1.88M | 5.2M | -74.16M | 0 | 1.51M |
Current Ratio | 0.32x | 5.98x | 0.67x | 0.38x | 2.10x | 2.29x | 1.72x |
Quick Ratio | 0.23x | 5.27x | 0.49x | 0.30x | 1.63x | 1.71x | 1.64x |
Cash Conversion Cycle | 62.07 | 61.71 | -30.71 | -49.73 | -521.16 | 215.38 | 132.19 |
Total Non-Current Liabilities | 24.78M | 12.21M | 11.82M | 5.3M | 7.58M | 4.45M | 0 |
Long-Term Debt | 24.59M | 9.41M | 8.99M | 0 | 696K | 4.45M | 0 |
Capital Lease Obligations | 184K | 5K | 2.3M | 3.57M | 5.62M | 0 | 3.85M |
Deferred Tax Liabilities | 0 | 2.79M | 0 | 0 | 1.26M | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 529.99K | 1.73M | 0 | 0 | 0 |
Total Liabilities | 79.36M | 19.55M | 33.86M | 70.8M | 7.15M | 8M | 25.08M |
Total Debt | 32.97M | 10.33M | 17.85M | 39.38M | 45.31M | 4.47M | 22.62M |
Net Debt | 28.98M | -18.61M | 16.19M | 37.31M | -585K | 3.16M | 2.07M |
Debt / Equity | - | 0.18x | 19.25x | - | 5.24x | 10.99x | 1.24x |
Debt / EBITDA | - | - | - | - | - | - | 4.72x |
Net Debt / EBITDA | - | - | - | - | - | - | 0.43x |
Interest Coverage | -5.42x | 2.06x | -1.55x | -4.26x | 0.66x | -18.36x | -7.75x |
Total Equity | -28.1M▲ 0% | 57.88M▲ 305.9% | 927.48K▼ 98.4% | -6.29M▼ 778.2% | 8.65M▲ 237.5% | 407K▼ 95.3% | 18.29M▲ 0% |
Equity Growth % | - | 305.95% | -98.4% | -778.15% | 237.49% | -95.29% | -1189.98% |
Book Value per Share | -151.15 | 116.27 | 1.32 | -0.51 | 5.35 | 0.02 | 0.06 |
Total Shareholders' Equity | -28.1M | 57.88M | 927.48K | -6.29M | -55.12M | 407K | 18.29M |
Common Stock | 52K | 29K | 7.27M | 8.8M | 22K | 31K | 419K |
Retained Earnings | -260.64M | -259.26M | -6.34M | -17.58M | -70.03M | -22.93M | -37.92M |
Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accumulated OCI | 0 | 0 | 0 | 2.49M | 2.4M | 0 | 0 |
Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SRXH Cash Flow Statement
SRx Health Solutions Inc. (SRXH) cash flow — operating, investing & free cash flow history
| Metric | Dec'20 | Dec'21 | Sep'22 | Sep'23 | Dec'24 | Sep'25 | TTM |
|---|---|---|---|---|---|---|---|
Cash from Operations | -7.59M | -11.86M | 4.67M | 3.87M | -4.36M | -8.14M | 1.06M |
Operating CF Margin % | -17.82% | -25.77% | 5.04% | 3.25% | -12.46% | -124.63% | - |
Operating CF Growth % | - | -56.23% | 139.36% | -17.16% | -212.7% | -86.89% | -748.37% |
Net Income | -59.34M | 2.98M | -2.45M | -11.14M | -43.05M | -8.64M | -45.39M |
Depreciation & Amortization | 1.75M | 1.66M | 1.33M | 2.87M | 4.39M | 31K | -1.15M |
Stock-Based Compensation | 0 | 0 | 0 | 2.95M | 3.67M | 0 | -1.25M |
Deferred Taxes | 0 | 0 | 0 | 0 | -1.12M | 0 | 682K |
Other Non-Cash Items | 49.82M | -14.66M | 7.31M | 15.35M | 31.34M | 133K | 13.15M |
Working Capital Changes | 175K | -1.85M | -1.53M | -6.16M | 426K | 332K | -1.36M |
Change in Receivables | 1.19M | -2.14M | 565.47K | -4.96M | -1.15M | 5.41M | 2.62M |
Change in Inventory | 1.45M | -642K | -1.89M | -746.55K | 2.74M | 496K | -1.44M |
Change in Payables | -2.44M | 773K | 0 | 0 | -1.16M | -5.99M | -11.99M |
Cash from Investing | -151K | -353K | -6.83M | -19.78M | -2.25M | 5.91M | -22.87M |
Capital Expenditures | -151K | -353K | -244.72K | -1.27M | 0 | 0 | -8.46M |
CapEx % of Revenue | 0.35% | 0.77% | 0.26% | 1.07% | 0.12% | - | -50.19% |
Acquisitions | 0 | 0 | -5.67M | -13.23M | -2.33M | 0 | 0 |
Investments | - | - | - | - | - | - | - |
Other Investing | 0 | 0 | -914.45K | -5.28M | 83K | 5.94M | -12.16M |
Cash from Financing | 9.2M | 37.16M | 3.8M | 16.43M | 5.22M | 12.17M | 53.29M |
Debt Issued (Net) | -9.9M | -3.02M | 3.91M | 11.38M | 675K | 12.31M | 7.99M |
Equity Issued (Net) | 19.1M | 40.18M | 0 | 0 | 4.55M | -137K | 37.29M |
Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Share Repurchases | 0 | -1.6M | 0 | 0 | -206K | -137K | -21.78M |
Other Financing | 0 | 0 | -107.88K | 5.06M | -1K | 0 | 8.02M |
Net Change in Cash | 1.46M▲ 0% | 24.95M▲ 1615.0% | 1.66M▼ 93.4% | 519K▼ 68.7% | -1.39M▼ 367.6% | -1.76M▼ 26.5% | 19.8M▲ 0% |
Free Cash Flow | -7.74M▲ 0% | -12.21M▼ 57.7% | 3.13M▲ 125.7% | 1.58M▼ 49.7% | -4.4M▼ 379.1% | -8.14M▼ 85.2% | 1.06M▲ 0% |
FCF Margin % | -18.18% | -26.54% | 3.38% | 1.32% | -12.57% | -124.63% | -6.27% |
FCF Growth % | - | -57.74% | 125.67% | -49.73% | -379.14% | -85.15% | 135.03% |
FCF per Share | -41.64 | -24.53 | 4.45 | 0.13 | -2.72 | -0.39 | 0.00 |
FCF Conversion (FCF/Net Income) | 0.13x | -3.97x | -1.91x | -0.35x | 25.93x | 0.18x | -0.02x |
Interest Paid | 0 | 0 | 0 | 0 | 2.66M | 458.87K | -1.22M |
Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
SRXH Key Ratios
SRx Health Solutions Inc. (SRXH) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|
Return on Equity (ROE) | 20.05% | -8.33% | - | -14.25% | -994.06% | 767.26% |
Return on Invested Capital (ROIC) | -64.57% | -3.1% | -18.09% | -10.93% | -31.76% | 6.89% |
Gross Margin | 29.79% | 14.36% | 19.85% | 36.77% | 22.88% | 28.25% |
Net Margin | 6.49% | -2.64% | -9.36% | -0.48% | -688.8% | 269.29% |
Debt / Equity | 0.18x | 19.25x | - | 5.24x | 10.99x | 1.24x |
Interest Coverage | 2.06x | -1.55x | -4.26x | 0.66x | -18.36x | -7.75x |
FCF Conversion | -3.97x | -1.91x | -0.35x | 25.93x | 0.18x | -0.02x |
Revenue Growth | 8.02% | 101.35% | 28.4% | -70.59% | -81.32% | -127.54% |
Related:SRXH Dividend History·SRXH Revenue History·SRXH Price History·SRXH P/E History·SRXH Financial Ratios·SRXH Institutional Holders
SRXH SEC Filings & Documents
SRx Health Solutions Inc. (SRXH) SEC filings — annual & quarterly reports (10-K, 10-Q)
SRXH Frequently Asked Questions
SRx Health Solutions Inc. (SRXH) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
SRx Health Solutions Inc. (SRXH) reported $-16.9M in revenue for fiscal year 2025. This represents a 140% decrease from $42.6M in 2020.
SRx Health Solutions Inc. (SRXH) saw revenue decline by 81.3% over the past year.
SRx Health Solutions Inc. (SRXH) reported a net loss of $45.4M for fiscal year 2025.
Dividend & Returns
SRx Health Solutions Inc. (SRXH) has a return on equity (ROE) of -994.1%. Negative ROE indicates the company is unprofitable.
SRx Health Solutions Inc. (SRXH) generated $1.1M in free cash flow for fiscal year 2025. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.